Risk minimization measures

Scientific Name Brand name Approval Date Last Update Details
Canakinumab Ilaris View
Rivaroxaban Xarelto  View
Rituximab Truxima  View
Adalimumab Idacio View
Sebelipase Alfa Kanuma View
Imiglucerase Cerezyme  View
Baricitinib Olumiant View
Haloperidol Haldol View
Pirfenidone Esbriet View
Sodium Valproate Epival View